StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJun 23, 2026, 09:15 PM

uniQure Prices Public Offering at $45.50/Share, Raising $225M

AI Summary

uniQure N.V. announced the pricing of its underwritten public offering of 4,945,055 ordinary shares at $45.50 per share. The offering is expected to generate approximately $225 million in gross proceeds for the company. Underwriters also have an option to purchase up to 741,758 additional shares, with the closing anticipated around June 25, 2026.

Key Highlights

  • Public offering priced at $45.50 per ordinary share.
  • Aggregate gross proceeds expected to be approximately $225 million.
  • uniQure is selling 4,945,055 ordinary shares in the offering.
  • Underwriters have a 30-day option to purchase up to 741,758 additional ordinary shares.
  • Offering is expected to close on or about June 25, 2026.